AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

PBMT Associated With a Pulmonary Rehabilitation Program on the Functional Capacity of Patients With COPD

RecruitingNAAges 18 Years - 90 YearsAllFederal University of Health Science of Porto Aleโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the effectiveness of photobiomodulation therapy (PBMT) as an adjunct to the pulmonary rehabilitation program on the functional capacity of patients with COPD. This is a randomized, placebo-controlled, double-blind clinical trial conducted with 20 patients from the outpatient clinic of the Integrated Cardiopulmonary and Metabolic Rehabilitation Service of Santa Casa de Porto Alegre. Patients will be allocated to the active PBMT group, receiving photobiomodulation treatment prior to the exercise protocol of the pulmonary rehabilitation program, in the respiratory and peripheral muscles, or the placebo group, which will receive the therapy application at the same points but without the therapeutic dose, prior to rehabilitation. Sixteen PBMT applications will be performed over eight weeks, with a frequency of twice a week. The exercises performed in the institutio

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with COPD, in the maintenance phase, with GOLD classification 3 and 4; * Ability to walk. Exclusion Criteria: * Cognitive dysfunction that prevents the completion of assessments, as well as inability to understand and sign the informed consent form (ICF); * Patients with sequelae of stroke; * Recent acute myocardial infarction (within two months); * Uncontrolled hypertension; * Heart failure grade IV according to the New York Heart Association or decompensated; * Unstable angina or arrhythmia; * Peripheral vascular alterations in lower limbs such as deep vein thrombosis; * Disabling osteoarticular or musculoskeletal disease; * Patients with cancer and/or undergoing cancer treatment; * Patients with systemic lupus erythematosus; * Pacemaker or cardiac defibrillator; * Hemophilia; * Recent skin lesions or tattoos at the site of therapy application.
๐Ÿ’Š

What it tests

  • Intervention Group
  • control group
๐Ÿ“

Where

1 site
Santa Casa de Porto Alegre
Porto Alegre, Brazil
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy